WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • Healthcare and FDA Regulatory
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • FDA Regulatory and Compliance

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

8.05.26

Wilson Sonsini Advises Discovery Loop on Launch and Initial Funding
On August 5, 2026, a founding team comprised of some of the world’s leading experts in artificial intelligence and distributed computing—Jeff Dean, Sanjay Ghemawat, Quoc Le, and Oriol Vinyals (alphabetical)—announced the launch of Discovery Loop, Inc., a Delaware public benefit corporation. Discovery Loop’s initial funding round is being co-led by Radical Ventures and Khosla Ventures, with participation from Lightspeed, Kleiner Perkins, Doerr Capital, and Alphabet. Wilson Sonsini Goodrich & Rosati is advising Discovery Loop on its launch and the financing.

The company aims to dramatically accelerate technological and scientific progress by automating complex science and engineering tasks. Specifically, it is developing advanced AI systems that leverage massive computational scale to fundamentally transform the speed and efficiency of innovation by automating complete experimental loops. In conjunction with its launch, Discovery Loop has established a long-term partnership with Alphabet for cloud and compute resources.

The Wilson Sonsini team advising Discovery Loop on its launch and initial financing includes Lang Liu, Barath Chari, Alyssa Worsham, Richa Sharma, Sunny Kumar, Will Andrews, MJ Han, Jing Xu, Robert Deng, Jason Choi, and Patrick Begian.

For more information, please see coverage in The Wall Street Journal, The New York Times, and Wired.
Client Highlights

8.05.26

Wilson Sonsini Advises Rambus on Accelerated Share Repurchase Program
On August 5, 2026, Rambus Inc., a provider of industry-leading chips and silicon IP for data center and artificial intelligence (AI) infrastructure, announced that it initiated an accelerated share repurchase program with Mizuho Markets Americas LLC to repurchase an aggregate of $100 million of its common stock. Wilson Sonsini Goodrich & Rosati is representing Rambus in the transaction.
Client Highlights

8.03.26

Wilson Sonsini Advises Base Power on $1 Billion Series D
On August 3, 2026, Base Power, a battery-powered home energy company based in Austin, Texas, announced it has raised $1 billion in a Series D financing at a $13 billion post-money valuation. The round was led by Ribbit, Addition, Valor Equity Partners, and JPMorganChase's Strategic Investment Group. Wilson Sonsini Goodrich & Rosati advised Base Power on the transaction.
Client Highlights

8.03.26

Wilson Sonsini Advises Firefly Bio on $1 Billion Acquisition by Johnson & Johnson
On July 29, 2026, Johnson & Johnson announced the completion of its acquisition of Firefly Bio, a biotechnology company advancing its proprietary Firelink™ degrader antibody conjugate platform, for $1 billion in cash. The Firelink™ DAC platform expands Johnson & Johnson’s oncology portfolio and advances the company’s ambition to develop targeted therapies for some of the most prevalent and difficult-to-treat solid tumors, including KRAS-driven cancers. Wilson Sonsini Goodrich & Rosati advised Firefly Bio on the transaction.
Alerts

7.30.26

Delaware Court of Chancery Issues First Decision Addressing Public Benefit Corporations
On July 29, 2026, Vice Chancellor Nathan Cook of the Delaware Court of Chancery issued a decision addressing, for the first time, the fiduciary duties of directors of a public benefit corporation (PBC)—including in a sale of control.1 Under the PBC form, the purpose of corporate decision-making is not merely to advance stockholder value—as is the ultimate purpose of decision-making for a traditional Delaware corporation—but instead to balance three sets of interests: a specific public benefit purpose chosen by the PBC, the best interests of those materially affected by the corporation’s conduct, and stockholders’ pecuniary interests.2 Delaware law first authorized the PBC form in 2013, and since that time, the form has grown in prominence, with many significant public and private companies operating as PBCs. Until this decision, however, there had not yet been direct case law guidance addressing PBCs. The decision, accordingly, is noteworthy for PBCs and companies considering adopting the PBC form.
Client Highlights

7.30.26

Firm Advises Lead Investor G2 Venture Partners and Eclipse on Antora Energy’s $500 Million Series C
On July 30, 2026, Antora Energy, a leading U.S. energy storage company, announced its closing on $550 million in Series C funding co-led by G2 Venture Partners and Eclipse, with participation from existing and new investors. Wilson Sonsini Goodrich & Rosati advised G2 Venture Partners and Eclipse on the transaction.
Client Highlights

7.30.26

Firm Advises Secturion Systems on Acquisition by Carlyle Group
On July 27, 2026, global investment firm Carlyle announced that it had acquired Secturion Systems, a leading provider of high-speed, NSA-certified hardware encryption solutions that protect sensitive and classified information. The transaction marks the first investment by Carlyle’s dedicated middle-market Aerospace, Defense & Government, and Industrials platform. Wilson Sonsini Goodrich & Rosati advised Secturion on the transaction.
Client Highlights

7.30.26

Wilson Sonsini Advises Dili on $15 Million Series A Led by Khosla Ventures
On July 30, 2026, Dili, an AI compliance company, announced it has raised $15 million in Series A funding. The round was led by Khosla Ventures, with participation from Allianz, Rebel Fund, Brick and Mortar Ventures' Darren Bechtel, and Y Combinator's Garry Tan. Wilson Sonsini Goodrich & Rosati advised Dili on the transaction.
Client Highlights

7.29.26

Wilson Sonsini Advises DroneDeploy on $845 Million Acquisition by Procore Technologies
On July 29, 2026, Procore Technologies, a global provider of construction management software, announced it has entered into a definitive agreement to acquire DroneDeploy, a robotics and visual intelligence platform. Procore will acquire DroneDeploy for approximately $845 million in cash, subject to customary purchase price adjustments. Wilson Sonsini Goodrich & Rosati is advising DroneDeploy on the transaction
Client Highlights

7.27.26

Firm Advises Forte Biosciences on $2.2 Billion Acquisition by argenx
On July 27, 2026, argenx, a global immunology innovation company, and Forte Biosciences, a clinical-stage biopharmaceutical company, announced that they have entered into a definitive agreement under which argenx will acquire Forte Biosciences for $77.00 per share in cash, representing a total equity value of approximately $2.2 billion. FB102, Forte Biosciences’ lead program, expands argenx’s portfolio of differentiated immunology medicines, adding a first-in-class anti-CD122 antibody with clinical proof-of-concept in vitiligo and celiac disease and potential to address multiple autoimmune diseases. Wilson Sonsini Goodrich & Rosati advised Forte Biosciences on the transaction.
Blog Posts

7.22.26

ISS Announces Launch of 2026 Annual Global Benchmark Policy Survey
ISS STOXX Governance (ISS) launched its 2026 Annual Global Benchmark Policy Survey, soliciting input on governance topics such as director tenure and independence, reincorporations, and the prospect of semiannual financial reporting, and, across all markets, is also soliciting views on slate board elections and climate-related disclosures. Responses are due by August 14, 2026, and will inform ISS's policy development for 2027 and beyond.
Blog Posts

7.21.26

SEC Proposes Regulation E-Delivery: What This Could Mean for Delivery of Your Proxy Materials
On July 16, 2026, the SEC proposed Regulation E-Delivery, a new framework that would permit issuers and market intermediaries to deliver required disclosures and reports electronically as the default method, without first obtaining a recipient's affirmative consent. The post summarizes the new framework and how issuer delivery of proxy materials could change.
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.